113 related articles for article (PubMed ID: 4691697)
1. Optimizing dermatological formulations of retinoic acid.
Schlichting DA; Wooding WM; Brown M
J Pharm Sci; 1973 Mar; 62(3):388-91. PubMed ID: 4691697
[No Abstract] [Full Text] [Related]
2. [Dermatotoxicity studies of calcipotriol (MC903) ointment--primary skin irritation, skin sensitization, phototoxicity and skin photosensitization].
Suzuki T; Kato T; Kitagaki T; Ono M; Shirakawa K; Nagata M; Konishi R
J Toxicol Sci; 1996 Jul; 21 Suppl 2():475-84. PubMed ID: 8741427
[TBL] [Abstract][Full Text] [Related]
3. [Studies on compatibility of tretinoin following systemic and topical application. 1. Toxicological studies].
Kretzschmar R; Leuschner F; Neumann W; Peh J; Zeller H
Arzneimittelforschung; 1974 Aug; 24(8):1193-9. PubMed ID: 4278561
[No Abstract] [Full Text] [Related]
4. Interspecies comparisons of skin irritancy.
Nixon GA; Tyson CA; Wertz WC
Toxicol Appl Pharmacol; 1975 Mar; 31(3):481-90. PubMed ID: 1145633
[No Abstract] [Full Text] [Related]
5. An intranasal irritation assessment of antibacterial ointment alone or in combination with mupirocin versus Bactroban Nasal in rabbits.
Faqi AS; Bell SJ; Gill S; Colagiovanni DB
Regul Toxicol Pharmacol; 2009 Oct; 55(1):28-32. PubMed ID: 19497343
[TBL] [Abstract][Full Text] [Related]
6. [Pastes and individual formulations].
Hautarzt; 2010 Dec; 61(12):1010-11. PubMed ID: 21125369
[No Abstract] [Full Text] [Related]
7. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis.
Eastman WJ; Malahias S; Delconte J; DiBenedetti D
Cutis; 2014 Jul; 94(1):46-53. PubMed ID: 25101344
[TBL] [Abstract][Full Text] [Related]
8. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
Mandawgade SD; Patravale VB
Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
[TBL] [Abstract][Full Text] [Related]
9. Topical malic acid in combination with citric acid: an option to treat recalcitrant warts.
Chiriac A; Brzezinski P
Dermatol Ther; 2015; 28(6):336-8. PubMed ID: 26176415
[No Abstract] [Full Text] [Related]
10. Testing for skin sensitization according to the notification procedure for new chemicals: the Magnusson and Kligman test.
Schlede E; Eppler R
Contact Dermatitis; 1995 Jan; 32(1):1-4. PubMed ID: 7720363
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of Alphastria cream in the prevention of pregnancy stretch marks (striae distensae). Results of a double-blind study].
de Buman M; Walther M; de Weck R
Gynakol Rundsch; 1987; 27(2):79-84. PubMed ID: 3305229
[No Abstract] [Full Text] [Related]
12. Dermatologic vehicles.
Ricciatti-Sibbald D; Sibbald RG
Clin Dermatol; 1989; 7(3):11-24. PubMed ID: 2680013
[No Abstract] [Full Text] [Related]
13. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
[TBL] [Abstract][Full Text] [Related]
14. The mystical effects of dermatological vehicles.
Surber C; Smith EW
Dermatology; 2005; 210(2):157-68. PubMed ID: 15724099
[TBL] [Abstract][Full Text] [Related]
15. Principles and approaches for optimizing therapy with unique topical vehicles.
Rosen J; Landriscina A; Friedman AJ
J Drugs Dermatol; 2014 Dec; 13(12):1431-5. PubMed ID: 25607783
[No Abstract] [Full Text] [Related]
16. Toxicity studies of methylcyclopentadienyl manganese tricarbonyl (MMT).
Hinderer RK
Am Ind Hyg Assoc J; 1979 Feb; 40(2):164-7. PubMed ID: 495448
[No Abstract] [Full Text] [Related]
17. [Dermatologic preparations with erythromycin--the correlation of the pharmaceutical form-therapeutic effect].
Cojocaru I; Irimia O; Constantin T
Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):166-9. PubMed ID: 10756791
[TBL] [Abstract][Full Text] [Related]
18. The use of retinoic acid in congenital ichthyosiform erythroderma.
Thomson J; Milne JA
Br J Dermatol; 1969 Jun; 81(6):452-5. PubMed ID: 5783771
[No Abstract] [Full Text] [Related]
19. Proposal of limit concentrations for skin irritation within the context of a new EEC directive on the classification and labeling of preparations.
Jacobs G; Martens M; Mosselmans G
Regul Toxicol Pharmacol; 1987 Dec; 7(4):370-8. PubMed ID: 3438501
[TBL] [Abstract][Full Text] [Related]
20. [Hydroxyethylated aliphatic alcohols in dermatology and cosmetics (a review of the literature)].
Griazina AG
Vestn Dermatol Venerol; 1975 Dec; (12):48-52. PubMed ID: 779329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
